Crescent Biopharma (CBIO) Competitors $10.25 -1.10 (-9.69%) As of 10/13/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CBIO vs. ZBIO, GERN, MYGN, VSTM, LXRX, RIGL, EBS, XOMA, VNDA, and IRWDShould you be buying Crescent Biopharma stock or one of its competitors? The main competitors of Crescent Biopharma include Zenas BioPharma (ZBIO), Geron (GERN), Myriad Genetics (MYGN), Verastem (VSTM), Lexicon Pharmaceuticals (LXRX), Rigel Pharmaceuticals (RIGL), Emergent Biosolutions (EBS), XOMA Royalty (XOMA), Vanda Pharmaceuticals (VNDA), and Ironwood Pharmaceuticals (IRWD). These companies are all part of the "biotechnology" industry. Crescent Biopharma vs. Its Competitors Zenas BioPharma Geron Myriad Genetics Verastem Lexicon Pharmaceuticals Rigel Pharmaceuticals Emergent Biosolutions XOMA Royalty Vanda Pharmaceuticals Ironwood Pharmaceuticals Crescent Biopharma (NASDAQ:CBIO) and Zenas BioPharma (NASDAQ:ZBIO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends. Does the media prefer CBIO or ZBIO? In the previous week, Zenas BioPharma had 47 more articles in the media than Crescent Biopharma. MarketBeat recorded 49 mentions for Zenas BioPharma and 2 mentions for Crescent Biopharma. Crescent Biopharma's average media sentiment score of 1.91 beat Zenas BioPharma's score of 0.48 indicating that Crescent Biopharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crescent Biopharma 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Zenas BioPharma 13 Very Positive mention(s) 6 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of CBIO or ZBIO? 75.2% of Crescent Biopharma shares are owned by institutional investors. 8.7% of Crescent Biopharma shares are owned by insiders. Comparatively, 16.5% of Zenas BioPharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts rate CBIO or ZBIO? Crescent Biopharma currently has a consensus target price of $25.60, suggesting a potential upside of 149.76%. Zenas BioPharma has a consensus target price of $38.33, suggesting a potential upside of 44.44%. Given Crescent Biopharma's stronger consensus rating and higher probable upside, research analysts clearly believe Crescent Biopharma is more favorable than Zenas BioPharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crescent Biopharma 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 3.33Zenas BioPharma 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has preferable earnings & valuation, CBIO or ZBIO? Crescent Biopharma has higher earnings, but lower revenue than Zenas BioPharma. Zenas BioPharma is trading at a lower price-to-earnings ratio than Crescent Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCrescent Biopharma$10K20,038.75-$37.88M-$34.93-0.29Zenas BioPharma$5M223.52-$156.99M-$3.55-7.48 Is CBIO or ZBIO more profitable? Zenas BioPharma's return on equity of -59.21% beat Crescent Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Crescent BiopharmaN/A -106.06% -86.60% Zenas BioPharma N/A -59.21%-50.56% SummaryCrescent Biopharma beats Zenas BioPharma on 9 of the 15 factors compared between the two stocks. Get Crescent Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBIO vs. The Competition Export to ExcelMetricCrescent BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$221.89M$2.61B$6.05B$10.30BDividend YieldN/A57.78%5.73%4.82%P/E Ratio-0.2922.5785.1927.10Price / Sales20,038.75755.26597.83133.24Price / CashN/A26.3325.7730.18Price / Book1.245.3512.626.69Net Income-$37.88M$33.06M$3.32B$276.55M7 Day Performance-9.21%0.13%-0.04%-0.40%1 Month Performance-17.93%9.75%8.73%6.53%1 Year PerformanceN/A-1.04%78.10%41.04% Crescent Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBIOCrescent Biopharma4.3412 of 5 stars$10.25-9.7%$25.60+149.8%N/A$221.89M$10K-0.2950Positive NewsZBIOZenas BioPharma2.2276 of 5 stars$20.85-9.5%$36.67+75.9%N/A$877.99M$15M-5.87N/AAnalyst RevisionHigh Trading VolumeGERNGeron2.4953 of 5 stars$1.29+0.8%$3.79+193.5%-70.7%$823.05M$76.99M-9.9270News CoverageMYGNMyriad Genetics3.6415 of 5 stars$7.53-5.8%$12.45+65.4%-67.4%$700.59M$837.60M-1.762,700VSTMVerastem2.8797 of 5 stars$9.00+4.5%$13.29+47.6%+212.8%$553.86M$10K-2.7450LXRXLexicon Pharmaceuticals2.7263 of 5 stars$1.52-1.9%$3.23+112.2%-17.2%$552.37M$31.08M-4.61140Positive NewsGap UpRIGLRigel Pharmaceuticals3.7815 of 5 stars$29.50+2.1%$38.20+29.5%+73.9%$529.14M$267.92M5.45160EBSEmergent Biosolutions4.312 of 5 stars$9.91+8.4%$13.50+36.3%+6.4%$528.43M$1.04B4.042,420XOMAXOMA Royalty4.0914 of 5 stars$37.16+1.5%$69.50+87.0%+31.1%$449.26M$28.49M-23.9710VNDAVanda Pharmaceuticals4.0932 of 5 stars$5.32-1.5%$16.50+210.2%+17.8%$314.36M$198.77M-4.71290IRWDIronwood Pharmaceuticals4.4545 of 5 stars$1.52+2.7%$4.94+225.0%-65.3%$246.90M$308.52M-30.39220News CoveragePositive NewsGap Up Related Companies and Tools Related Companies Zenas BioPharma Competitors Geron Competitors Myriad Genetics Competitors Verastem Competitors Lexicon Pharmaceuticals Competitors Rigel Pharmaceuticals Competitors Emergent Biosolutions Competitors XOMA Royalty Competitors Vanda Pharmaceuticals Competitors Ironwood Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBIO) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneInvestors are quietly piling into this secret AI stock Elon hates… It's one of those things you just need t...Economic Media | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescent Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescent Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
